INOVIO PHARMACEUTICALS, INC. short interest in 2023
In 2023, INOVIO PHARMACEUTICALS, INC.'s disclosed short interest ran from 17.95% of shares outstanding on 13 Jan 2023 to 8.75% on 29 Dec 2023, a change of -9.20 percentage points. The year's high was 17.95% on 13 Jan 2023 and its low 5.56% on 29 Sep 2023, averaging 11.73% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.60 days on 30 Nov 2023. Full history: INOVIO PHARMACEUTICALS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 17.95% (13 Jan 2023)
- End of year
- 8.75% (29 Dec 2023)
- Change
- -9.20 pp
- High
- 17.95% (13 Jan 2023)
- Low
- 5.56% (29 Sep 2023)
- Average
- 11.73%
- Highest days to cover
- 13.60 (30 Nov 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 17.95% | 9.66 | |
| 31 Jan 2023 | 17.53% | 10.85 | |
| 15 Feb 2023 | 16.20% | 7.87 | |
| 28 Feb 2023 | 15.48% | 10.59 | |
| 15 Mar 2023 | 15.19% | 9.76 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 13.38% | 6.92 | |
| 14 Apr 2023 | 15.24% | 4.27 | |
| 28 Apr 2023 | 15.19% | 8.18 | |
| 15 May 2023 | 15.09% | 7.80 | 10-Q filed, results (8-K) |
| 31 May 2023 | 16.45% | 3.98 | |
| 15 Jun 2023 | 16.85% | 4.53 | |
| 30 Jun 2023 | 9.27% | 1.28 | |
| 14 Jul 2023 | 8.04% | 2.72 | |
| 31 Jul 2023 | 8.30% | 6.91 | |
| 15 Aug 2023 | 8.23% | 8.26 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 6.23% | 9.00 | |
| 15 Sep 2023 | 5.83% | 6.27 | |
| 29 Sep 2023 | 5.56% | 8.43 | |
| 13 Oct 2023 | 9.59% | 2.74 | |
| 31 Oct 2023 | 9.30% | 7.58 | |
| 15 Nov 2023 | 9.50% | 11.84 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 9.42% | 13.60 | |
| 15 Dec 2023 | 8.89% | 11.27 | |
| 29 Dec 2023 | 8.75% | 9.64 |
See also: INOVIO PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.